Visceral Fat: The Invisible Enemy Your Weight Doesn't Reveal
You can be a "normal" weight and still have too much visceral fat. You can have a perfect BMI and a high cardiovascular risk. You can feel fine and have organs wrapped in fat that silently compresses and inflames them. The scale lies — and science clearly says so.
Subcutaneous Fat vs. Visceral Fat: The Difference That Matters
Not all body fat is the same. There are two fundamentally different types:
Subcutaneous Fat
This is the fat you can pinch under your skin — hips, thighs, arms. It's visible, can be aesthetically annoying, but metabolically it is relatively harmless. The body uses it as an energy reserve and thermal insulator.
Visceral Fat
This is the fat that accumulates around internal organs — liver, pancreas, intestines, heart. It is not visible from the outside. A person with a "flat" abdomen can have high visceral fat; conversely, an overweight person can have relatively low amounts.
Visceral fat is metabolically active and inflammatory: it produces substances called adipokines and pro-inflammatory cytokines that enter the bloodstream directly through the hepatic portal vein. These molecules promote:
- Insulin resistance (and therefore type 2 diabetes)
- Chronic systemic inflammation
- Dyslipidemia (high LDL cholesterol, low HDL, high triglycerides)
- Arterial hypertension
- Non-alcoholic fatty liver disease (NAFLD)
The Frightening Data: NEJM and Cardiovascular Risk
In 2008, the New England Journal of Medicine published a study of over 350,000 European participants that changed the way medicine views body weight. The conclusion:
"Abdominal fat — measured by waist circumference — is a stronger predictor of cardiovascular mortality than BMI. People with a normal BMI but high waist circumference have nearly double the risk of death compared to those with the same BMI but a normal waistline."
— Pischon T. et al., NEJM 2008
A second crucial study, published in The Lancet in 2011 on 58 prospective cohorts and over 220,000 participants, confirmed: waist circumference is an independent predictor of cardiovascular mortality, even after adjustment for BMI.
In simple words: it's not just about how much you weigh, it's about where your weight is distributed.
Italian Data: The Hidden Problem
The ISTAT BES 2024 Report (Fair and Sustainable Well-being) depicts a worrying reality:
- 46% of Italian adults are overweight or obese
- Abdominal obesity (waist circumference >88 cm in women, >102 cm in men) affects approximately 25% of the adult population
- The trend is increasing: in the last 10 years, abdominal obesity has increased by 15% in 35–54 year olds
- Only 31% of Italians regularly monitor their weight — and almost no one measures body composition
Why BMI is Not Enough
BMI (Body Mass Index = weight in kg ÷ height² in meters) was developed in 1830 by Belgian astronomer Adolphe Quetelet as a statistical tool for populations — not to assess the health of an individual.
Its limitations are numerous:
- It does not distinguish muscle mass from fat: an athlete can have an "overweight" BMI with a very low body fat percentage
- It does not localize fat: a BMI of 24 with all fat concentrated on the abdomen is much riskier than a BMI of 27 with fat distributed on the hips and thighs
- It does not measure visceral fat: two people with identical BMIs can have radically different amounts of visceral fat
- It varies with age: with aging, muscle mass decreases and fat increases — but BMI remains unchanged
Studies published in the Journal of the American Medical Association (JAMA) have shown that about 30% of people with a "normal" BMI (18.5–24.9) have a metabolically obese body composition — with high visceral fat and increased cardiovascular risk. This phenomenon is called MONW (Metabolically Obese Normal Weight).
How to Measure Visceral Fat
The Gold Standard: DEXA (Dual-energy X-ray Absorptiometry)
DEXA scan is the most precise method for measuring total body composition, including visceral fat. Cost: €150–400 per exam, available in specialized centers and hospitals. It is not practical for routine monitoring.
CT and MRI
Even more precise than DEXA for estimating visceral fat, but invasive (radiation for CT), expensive, and inaccessible for home monitoring.
Waist Circumference
A quick and free tool. High-risk values: >80 cm for women, >94 cm for men (according to ESC 2023). It correlates well with visceral fat but does not quantify it precisely and does not distinguish between fat types.
Bioelectrical Impedance Analysis (BIA)
A technique that measures body composition by analyzing how the body conducts a low-intensity (harmless) electrical current. Fat conducts less than water and muscle mass — from this difference, body parameters are calculated. It is the most accessible method for home monitoring with good correlation to clinical DEXA.
Single vs. Dual Frequency BIA: The Technical Difference
Not all impedance scales are created equal. The key difference is the number of current frequencies used:
Single Frequency (50kHz)
Most consumer scales use only one frequency. At 50kHz, the current primarily analyzes extracellular fluids. The result is an estimate of total body fat, but with lower accuracy for compartment distinction.
Dual Frequency (50kHz + 250kHz)
The 50kHz current analyzes extracellular fluids. At 250kHz, it penetrates the cell membrane and also measures intracellular fluids. This allows for more precise distinction of:
- Total body fat
- Skeletal muscle mass
- Visceral fat (level 1–59)
- Total body water (intracellular + extracellular)
- Estimated bone mass
- Basal metabolic rate
The correlation with DEXA for quality clinical dual-frequency BIA scales reaches r > 0.90 — significantly higher than single-frequency scales.
The 25 Parameters a Clinical Scale Measures
A clinical-grade impedance scale does more than just give a fat number. The VitaeChek Brio 1 Pro — with dual-frequency BIA technology 50kHz + 250kHz — measures 25 body parameters, including:
- Body weight
- BMI
- Body fat percentage
- Fat mass (kg)
- Visceral fat (level 1–59) — the most important parameter for metabolic health
- Skeletal muscle mass
- Segmental muscle mass (arms, legs, trunk)
- Total body water
- Estimated bone mass
- Basal metabolic rate (BMR)
- Metabolic age
- Resting heart rate
- Body score
The Athlete Mode optimizes algorithms for individuals with high muscle hydration (regular athletes), avoiding overestimation of body fat typical of standard scales.
How to Interpret Visceral Fat Level
Visceral fat is expressed in levels on a scale of 1–59:
| Level | Classification | Clinical Indication |
|---|---|---|
| 1–9 | Normal | Low metabolic risk |
| 10–14 | High | Monitoring recommended, lifestyle intervention |
| 15–30 | Very High | Elevated cardiovascular and metabolic risk — medical consultation |
| > 30 | Critical | Very high risk — urgent medical evaluation |
How to Reduce Visceral Fat: Science Speaks Clearly
The good news: visceral fat responds to treatment better than subcutaneous fat. Strategies with the strongest scientific evidence:
- Moderate caloric deficit (300–500 kcal/day): studies show a 10–30% reduction in visceral fat in 12 weeks
- Aerobic exercise (150 min/week of moderate intensity): the most effective way to reduce visceral fat even without weight changes
- Weight training: increases muscle mass and improves insulin sensitivity — indirectly reduces visceral fat
- Reduction of simple sugars: excess fructose preferentially deposits as hepatic and visceral fat
- Adequate sleep (7–9 hours): chronic sleep deprivation increases cortisol, which promotes visceral fat accumulation
- Stress management: chronic cortisol is the main driver of visceral adipogenesis
Monitoring as a Tool for Change
Regularly measuring body composition is not just informative — it's motivational. Studies on self-monitoring theory show that people who track their progress are twice as likely to achieve their goals as those who don't measure themselves.
Visceral fat can significantly decrease even without changes in weight on a traditional scale — especially in the first few weeks of intervention, when fat is lost but muscle mass is gained. Without BIA measurement, these progressions would be invisible and demotivating.
→ Discover the VitaeChek Brio 1 Pro — dual-frequency BIA scale with 25 body parameters
Sources
- Pischon T. et al. — General and Abdominal Adiposity and Risk of Death in Europe, NEJM 2008
- Emerging Risk Factors Collaboration — Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease, The Lancet 2011
- Romero-Corral A. et al. — Normal Weight Obesity: a risk factor for cardiometabolic dysregulation, The Lancet 2010
- ISTAT — Rapporto BES 2024: Benessere Equo e Sostenibile in Italia
- Ross R. et al. — Waist circumference as a vital sign in clinical practice, Nature Reviews Endocrinology 2020
- Després JP. — Abdominal obesity: the most prevalent cause of the metabolic syndrome, Acta Diabetologica 2006